Submitted by Anonymous (not verified) on 5 March 2025 - 15:45
Human medicines European public assessment report (EPAR): Enerzair Breezhaler, indacaterol,glycopyrronium bromide,mometasone, Date of authorisation: 03/07/2020, Revision: 9, Status: Authorised
Source: